Francis Kalemeera (F Kalemeera)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 11

Top Venues

Hospital practice (1995)

Pharmacology research & perspectives

Expert opinion on drug safety

BioMed research international

University of Namibia

University of Namibia (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Namibia Oct 01 2013

Namibia

Senior Lecturer :: Pharmacology, Pharmacy Policy and Practice

Management Sciences for Health Dec 21 2009 - Aug 31 2013

Namibia

Senior Technical Advisor

Makerere University Infectious Diseases Institute Jun 01 2005 - Dec 17 2009

Uganda

Clinical Pharmacist :: Training

Pharma-Health Ltd Feb 01 2003 - Dec 17 2009

Uganda

Pharmacist Director :: Community Pharmacy

Education History

University of Namibia Jan 15 2015

Namibia

PHD :: Pharmacy Practice and Policy

University College Cork Jun 15 2007 - Jun 15 2009

Ireland

MSC

Publications

Francis Kalemeera, Brian B Godman, Andy Stergachis, Timothy William Rennie
Effect of tenofovir containing ART on renal function in patients with moderate/severe reduced creatinine clearance at baseline: A retrospective study at two referral hospitals in Namibia. Pharmacology research & perspectives 11 (1) (2023)
Francis Kalemeera, Brian B Godman, Andy Stergachis, Timothy William Rennie
Effect of tenofovir containing ART on renal function in patients with moderate/severe reduced creatinine clearance at baseline: A retrospective study at two referral hospitals in Namibia. Pharmacology research & perspectives 11 (1) (2023)
Francis Kalemeera, Brian B Godman, Andy Stergachis, Timothy William Rennie
Effect of tenofovir containing ART on renal function in patients with moderate/severe reduced creatinine clearance at baseline: A retrospective study at two referral hospitals in Namibia. Pharmacology research & perspectives 11 (1) (2023)
Brian B Godman, Abiodun Egwuenu, Evelyn Wesangula, Natalie Schellack, Aubrey Chichonyi Kalungia, Celda Tiroyakgosi, Joyce Kgatlwane, Julius Chacha Mwita, Okwen Patrick, Loveline Lum Niba, Adefolarin A Amu, Racheal Tomilola Oguntade, Mobolaji Eniola Alabi, Nondumiso B Q Ncube, Israel Abebrese Sefah, Joseph Acolatse, Robert Incoom, Anastasia Nkatha Guantai, Margaret Oluka, Sylvia Opanga, Ibrahim Chikowe, Felix Khuluza, Francis K Chiumia, Collins Edward Jana, Francis Kalemeera, Ester Hango, Joseph Olusesan Fadare, Olanyika O Ogunleye, Bernard E Ebruke, Johanna Catharina Meyer, Amos Massele, Oliver Ombeva Malande, Dan Kibuule, Otridah Kapona, Trust Zaranyika, Mutsa Bwakura-Dangarembizi, Tapiwanashe Kujinga, Zikria Saleem, Amanj Baker Kurdi, Moyad Shahwan, Ammar Abdulrahman Jairoun, Janney Wale, Adrian J Brink
Tackling antimicrobial resistance across sub-Saharan Africa: current challenges and implications for the future. Expert opinion on drug safety 21 (8) (2022)
Francis Kalemeera, S T Ndevahoma, M Mubita, Brian Godman
Evaluation of Namibia's antiretroviral therapy guidelines' recommendations for switching from first-line to second-line, using predictors of first-line treatment failure: an exploratory study. Expert review of anti-infective therapy (2021)
Brian B Godman, Magdalene Wladysiuk, Stuart McTaggart, Amanj Baker Kurdi, Eleonora Allocati, Mihajlo Michael Jakovljevic, Francis Kalemeera, Iris Hoxha, Anna Nachtnebel, Robert Sauermann, Manfred Hinteregger, Vanda Marković-Peković, Biljana Tubic, Guenka Petrova, Konstantin Tachkov, Juraj Slabý, Radka Nejezchlebova, Iva Selke Krulichová, Ott Laius, Gisbert W Selke, Irene Langner, András Harsanyi, András Inotai, Arianit Jakupi, Svens Henkuzens, Kristina Garuolienė, Jolanta Gulbinovič, Patricia Vella Bonanno, Jakub Rutkowski, Skule Ingeberg, Øyvind Melien, Ileana Mardare, Jurij Fürst, Sean MacBride-Stewart, Carol Holmes, Caridad Pontes, Corinne Zara Yahni, Marta Turu Pedrola, Mikael Hoffmann, Vasileios Kourafalos, Alice Pisana, Rita Banzi, Stephen Campbell, Björn Wettermark
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications. BioMed research international 2021 (2021)
Ester Hango, Kristofina Amakali, Anna Shilunga, Dan Kibuule, Brian B Godman, Francis Kalemeera
Assessing smoking cessation services and pharmacotherapy in Namibia: findings and implications for future policy initiatives. Expert review of pharmacoeconomics & outcomes research (2021)
Pia Simeon, Brian B Godman, Francis Kalemeera
Antibiotics' susceptibility patterns of bacterial isolates causing lower respiratory tract infections in ICU patients at referral hospitals in Namibia. Hospital practice (1995) (2021)
Brian B Godman, Debashis Basu, Yogan Pillay, Paulo Henrique Ribeiro Fernandes Almeida, Julius Chacha Mwita, Godfrey Mutashambara Rwegerera, Bene D Anand Paramadhas, Celda Tiroyakgosi, Okwen Patrick, Loveline Lum Niba, Israel Abebrese Sefah, Margaret Oluka, Anastasia N Guantai, Dan Kibuule, Francis Kalemeera, Mwangana Mubita, Joseph Olusesan Fadare, Olanyika O Ogunleye, Enos M Rampamba, Jeffrey Wing, Debjani Mueller, Abubakr Alfadl, Adefolarin A Amu, Zinhle Matsebula, Aubrey Chichonyi Kalungia, Trust Zaranyika, Nyasha Masuka, Janney Wale, Ruaraidh A Hill, Amanj Baker Kurdi, Angela Timoney, Stephen M Campbell, Johanna Catharina Meyer
Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future. Hospital practice (1995) 48 (2) (2020)
Francis Kalemeera, Brian B Godman, A Stergachis, T Rennie
Effect of TDF-containing regimens on creatinine clearance in HIV patients in Namibia with a baseline CrCl <60ml/min; findings and implications. Hospital practice (1995) 48 (1) (2020)
Francis Kalemeera, Brian Godman, Andy Stergachis, Timothy Rennie
Tenofovir disoproxil fumarate associated nephrotoxicity: a retrospective cohort study at two referral hospitals in Namibia. Pharmacoepidemiology and drug safety 30 (2) (2020)

Francis Kalemeera.css-eqlu8i{font-size:small;padding-left:4px;} (F Kalemeera)

Publication Activity (10 Years)

Top Topics

Top Venues

Francis Kalemeera (F Kalemeera)